BIOLOGICAL · Unmapped registry intervention
GPI-0100
Find medicine records ·
Find other trials using this name
Clinical trial
Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
NCT00016146
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
MUC-2-Globo H-KLH conjugate vaccine
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedVaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
GPI-0100BIOLOGICAL
MUC-2-Globo H-KLH conjugate vaccineBIOLOGICAL
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00016146 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.